Does Sjögren’s Syndrome Cause Weight Gain?

Sjögren’s syndrome does not directly cause weight gain the way, say, an underactive thyroid slows your metabolism. But a significant share of people with the disease do gain weight after diagnosis, and the reasons are tangled up in fatigue, pain, overlapping hormonal conditions, and the inflammatory biology of the disease itself. The relationship between Sjögren’s and body weight turns out to be surprisingly complicated, with research suggesting the link runs in both directions and that excess weight may even alter how the disease behaves.

How Common Is Excess Weight Among Sjögren’s Patients

Researchers looking at a cohort of patients with primary Sjögren’s disease found that about one in five was obese by standard BMI criteria. But BMI is a rough tool, and when the same group was assessed using waist circumference, waist-to-hip ratio, and fat mass index, the obesity rates jumped to roughly a third or even half the group, depending on the measure used.¹ That gap matters because it suggests many Sjögren’s patients carry excess fat that standard screening misses, particularly around the abdomen.

A large prospective study using UK Biobank data took a different angle, asking whether body composition predicts who develops Sjögren’s in the first place. It found that higher body fat mass was associated with an increased risk of developing the disease. Whole-body fat mass index, for example, was linked to roughly 60 percent higher risk.² Interestingly, the relationship between BMI and Sjögren’s risk was U-shaped, meaning that very low body weight was also associated with higher risk. This is one reason researchers have had trouble pinning down a simple answer to the weight question: the relationship is not a straight line.

Fatigue and Pain Make It Hard to Stay Active

If you have Sjögren’s, you already know that fatigue is one of the most disabling symptoms, often more burdensome than the hallmark dry eyes and dry mouth. That relentless tiredness, combined with joint and muscle pain, creates a practical barrier to exercise that directly contributes to weight gain over time. A study examining physical activity levels in primary Sjögren’s patients found that the most common barriers to staying active were lack of motivation, fatigue, and pain. Reduced pain was one of the strongest predictors of maintaining an active lifestyle.³

This creates a feedback loop that many people with chronic autoimmune conditions recognize. You feel exhausted, so you move less. Moving less leads to deconditioning and gradual weight gain. The extra weight can worsen joint stress and fatigue, which makes exercise even harder. Breaking that cycle is one of the most important and most difficult parts of managing the disease long-term. The same research pointed to the need for tailored programs that address psychological factors alongside pain management, rather than just telling patients to exercise more.

The Thyroid Connection

One of the most underappreciated reasons Sjögren’s patients gain weight is that the disease frequently travels with thyroid problems. Primary Sjögren’s syndrome was found to be about ten times more common in people with autoimmune thyroid disease, and autoimmune thyroiditis was about nine times more common in people with Sjögren’s. The most frequently detected hormonal pattern was subclinical hypothyroidism, and over a follow-up of more than ten years, hypothyroidism was the most common autoimmune condition that Sjögren’s patients went on to develop.⁴

Even subclinical hypothyroidism, where thyroid hormone levels are technically still in the normal range but the gland is starting to underperform, can slow metabolism enough to cause gradual weight gain and make losing weight frustratingly difficult. If you have Sjögren’s and have noticed unexplained weight creeping up despite no major changes in diet or activity, getting your thyroid checked is worth the conversation. Many patients are never screened for thyroid disease until years after their Sjögren’s diagnosis, by which point the weight gain has already become entrenched.

Metabolic Syndrome and the Inflammation Overlap

Sjögren’s is fundamentally an inflammatory disease, and chronic inflammation does not stay neatly contained in the salivary and tear glands. Research has shown that Sjögren’s patients have elevated levels of several inflammatory molecules, including IL-1 beta, IL-6, and a B-cell activating factor called BAFF, as well as abnormal levels of fat-signaling hormones like resistin and adiponectin, compared to healthy controls.⁵ These are not just markers of autoimmune activity. They are the same molecules that drive metabolic syndrome, a cluster of conditions including abdominal obesity, high blood pressure, elevated blood sugar, and abnormal cholesterol.

When researchers compared Sjögren’s patients who met criteria for metabolic syndrome to those who did not, the metabolic syndrome group had higher BMI, larger waist circumference, higher insulin and leptin levels, and higher insulin resistance scores. They also had elevated IL-1 beta levels even after adjusting for steroid use and other confounders.⁵ The implication is that inflammation from Sjögren’s itself may help set the stage for metabolic dysfunction, and metabolic dysfunction in turn promotes further inflammation and fat accumulation. It is not that Sjögren’s “causes” weight gain through a single mechanism so much as the disease creates inflammatory soil where metabolic problems take root more easily.

Animal research supports this picture. In a mouse model of Sjögren’s, inducing metabolic abnormalities worsened both the severity of the autoimmune disease and the levels of inflammatory cytokines in the salivary glands, along with an increase in certain pro-inflammatory immune cells throughout the body.⁶ This suggests the relationship is genuinely bidirectional: Sjögren’s promotes metabolic trouble, and metabolic trouble makes Sjögren’s worse.

Adiponectin and Fat-Signaling Hormones

One wrinkle that puzzles researchers is the behavior of adiponectin in Sjögren’s patients. Adiponectin is a hormone released by fat cells that normally helps regulate blood sugar and has anti-inflammatory properties. In most conditions associated with obesity, adiponectin levels drop as fat mass rises. But in Sjögren’s, adiponectin levels are significantly elevated compared to healthy controls. One study found that women with Sjögren’s had average adiponectin levels nearly 70 percent higher than controls, alongside elevated IL-6.⁷

This is unusual because high adiponectin is typically seen as protective against weight gain and metabolic problems. In the context of autoimmune diseases, though, chronically high adiponectin may actually reflect the body’s attempt to counterbalance ongoing inflammation rather than a sign of metabolic health. The fat-signaling hormone profile in Sjögren’s does not follow the standard playbook, which is part of why managing weight in this population requires more than just calorie math.

Why Sjögren’s Peaks When Weight Gain Is Already Common

Sjögren’s disease is overwhelmingly female, and its incidence peaks during perimenopause.⁸ This timing creates a diagnostic challenge because perimenopause itself is associated with shifts in body composition, particularly a redistribution of fat toward the abdomen, reduced muscle mass, and metabolic slowdown driven by declining estrogen. When a woman in her late forties or early fifties starts gaining weight and feeling exhausted, it is easy for both patient and physician to attribute everything to menopause and miss the autoimmune component entirely.

The overlap also makes it harder to tease apart what is causing weight gain in any individual patient. Is it the Sjögren’s-related fatigue? The subclinical thyroid disease that often accompanies it? The hormonal shifts of perimenopause? Reduced activity from joint pain? Usually, the honest answer is some combination of all of these, each feeding into the others.

The Surprising Finding About Obesity and Disease Severity

One of the more counterintuitive findings in Sjögren’s research is that obese patients sometimes show lower scores on standard measures of disease activity. In one cohort, the median disease activity index score for obese patients was 2, compared to 4 in non-obese patients, a statistically significant difference. Obese patients in the same study also required steroid therapy less often than their leaner counterparts.⁹

Before you conclude that extra weight is protective, the picture is more complicated. When the researchers ran a regression analysis adjusting for multiple factors, obesity did not independently predict lower disease activity in a statistically significant way, though there was a trend in that direction. And the disease activity index used in these studies primarily measures organ-level inflammation and glandular damage, not subjective symptoms like fatigue and pain, which are often what affect quality of life most. A patient can have a low disease activity score and still feel terrible. The finding is interesting from a biological standpoint, possibly reflecting differences in immune regulation at different body compositions, but it should not be taken as a reason to embrace weight gain.

When Sjögren’s Causes Weight Loss Instead

While the more common concern is weight gain, Sjögren’s can also cause dramatic weight loss in some patients. The disease sometimes affects the gastrointestinal tract, and in rare cases, severe complications can develop. One documented case involved a woman with Sjögren’s who lost about 95 pounds over five years due to a condition called protein-losing gastroenteropathy, arriving at the hospital cachectic with worsening abdominal pain, diarrhea, and electrolyte problems.¹⁰

Less dramatically, the chronic dry mouth that defines Sjögren’s can make eating genuinely difficult. Food does not taste the same, swallowing can be painful, and dental problems from reduced saliva may make chewing uncomfortable. Some patients lose their appetite or begin avoiding foods they previously enjoyed. Unintentional weight loss in a Sjögren’s patient always warrants investigation because it can signal gastrointestinal involvement, lymphoma (a known risk with Sjögren’s), or other complications that need treatment.

Gut Microbiome Differences

Researchers have found that the gut microbiome of Sjögren’s patients looks meaningfully different from that of healthy people. A study comparing the two groups found that certain bacteria were enriched in Sjögren’s patients while butyrate-producing bacteria, which are generally considered beneficial for gut health and metabolic regulation, were less abundant.¹¹ Butyrate is a short-chain fatty acid that helps maintain the gut lining, regulate inflammation, and support healthy metabolism. A deficit in the bacteria that produce it could contribute to both the inflammatory and metabolic features of the disease.

This is still early-stage research, and nobody should be drawing firm conclusions about probiotics or microbiome-targeted therapies for Sjögren’s yet. But the gut findings do add another plausible pathway by which the disease could tilt the body toward metabolic dysfunction and, eventually, weight gain. The gut microbiome is deeply intertwined with immune regulation, and in a disease defined by immune system misbehavior, the gut connection is receiving increasing attention.

What Helps With Weight Management

Given the multiple overlapping forces pushing weight upward in Sjögren’s, managing weight requires addressing several things at once rather than focusing on diet alone. Current expert guidance suggests that a Mediterranean-style diet and regular aerobic exercise offer benefits for cardiovascular risk factors in Sjögren’s patients.¹² The emphasis on Mediterranean eating is partly about anti-inflammatory properties: diets rich in olive oil, fish, vegetables, and whole grains tend to reduce the same inflammatory markers that are elevated in Sjögren’s.

Exercise is the other pillar, but the approach needs to be realistic. The research on physical activity barriers in Sjögren’s suggests that programs are more successful when they account for pain and psychological factors rather than prescribing generic fitness routines.³ For many patients, that means starting with low-impact activities like swimming, walking, or gentle cycling, and building from a baseline that acknowledges your current energy levels rather than some aspirational standard. The goal is consistency over intensity, especially early on.

Screening for and treating overlapping conditions is equally important. If subclinical hypothyroidism is nudging your metabolism downward, addressing it with thyroid hormone replacement can make a real difference. If insulin resistance is developing, catching it early gives you more options. If steroid use for disease flares is contributing to weight gain, discussing steroid-sparing alternatives with your rheumatologist can help break the cycle. None of these steps is glamorous, but together they address the actual web of causes rather than treating weight gain as a standalone problem disconnected from the underlying disease.

Sleep, Depression, and Body Composition

One study examining Sjögren’s patients found that overweight patients with higher lean mass tended to report better sleep quality.¹³ That may sound counterintuitive if you expect excess weight to be universally harmful, but it highlights an important nuance: not all weight is the same. Lean mass, which you build through resistance training and adequate protein intake, plays a different metabolic and functional role than fat mass. Muscle tissue supports joint stability, improves insulin sensitivity, and appears to be linked to better sleep in this population.

Depression and poor sleep are both common in Sjögren’s, and both independently promote weight gain through hormonal pathways involving cortisol, ghrelin, and leptin. When sleep is disrupted, hunger hormones shift in ways that increase appetite and cravings for calorie-dense foods. When depression saps your motivation, the fatigue from the disease feels even heavier, and the path of least resistance becomes inactivity. Addressing sleep quality and mental health is not a side issue in Sjögren’s weight management; for some patients, it is the central issue.